103 related articles for article (PubMed ID: 30735462)
1. Provider-level rates of HEDIS-consistent HPV vaccination in a regional health plan.
Panozzo CA; Gilkey MB; Kornides ML; Wharam JF
Hum Vaccin Immunother; 2019; 15(7-8):1708-1714. PubMed ID: 30735462
[No Abstract] [Full Text] [Related]
2. Provider factors associated with disparities in human papillomavirus vaccination among low-income 9- to 17-year-old girls.
Vadaparampil ST; Staras SA; Malo TL; Eddleton KZ; Christie J; Rodriguez M; Giuliano AR; Shenkman EA
Cancer; 2013 Feb; 119(3):621-8. PubMed ID: 23341308
[TBL] [Abstract][Full Text] [Related]
3. Supporting Human Papillomavirus Vaccination in Adolescents: Perspectives From Commercial and Medicaid Health Plans.
Ng JH; Sobel K; Roth L; Byron SC; Lindley MC; Stokley S
J Public Health Manag Pract; 2017; 23(3):283-290. PubMed ID: 27798527
[TBL] [Abstract][Full Text] [Related]
4. Implementation of Strategies to Improve Human Papillomavirus Vaccine Coverage: A Provider Survey.
Walling EB; Dodd S; Bobenhouse N; Reis EC; Sterkel R; Garbutt J
Am J Prev Med; 2019 Jan; 56(1):74-83. PubMed ID: 30573149
[TBL] [Abstract][Full Text] [Related]
5. Utilization of administrative data to assess the association of an adolescent health check-up with human papillomavirus vaccine uptake in Germany.
Rieck T; Feig M; Deleré Y; Wichmann O
Vaccine; 2014 Sep; 32(43):5564-9. PubMed ID: 25131739
[TBL] [Abstract][Full Text] [Related]
6. A model of health care provider decision making about HPV vaccination in adolescent males.
Alexander AB; Best C; Stupiansky N; Zimet GD
Vaccine; 2015 Aug; 33(33):4081-6. PubMed ID: 26143612
[TBL] [Abstract][Full Text] [Related]
7. A Comparison of Parent- and Provider-Reported Human Papillomavirus Vaccination of Adolescents.
Adjei Boakye E; Tobo BB; Osazuwa-Peters N; Mohammed KA; Geneus CJ; Schootman M
Am J Prev Med; 2017 Jun; 52(6):742-752. PubMed ID: 27890518
[TBL] [Abstract][Full Text] [Related]
8. Parent report of provider HPV vaccine communication strategies used during a randomized, controlled trial of a provider communication intervention.
Dempsey AF; Pyrzanowski J; Campagna EJ; Lockhart S; O'Leary ST
Vaccine; 2019 Feb; 37(10):1307-1312. PubMed ID: 30733088
[TBL] [Abstract][Full Text] [Related]
9. Human Papillomavirus Infection and Vaccination.
Valentino K; Poronsky CB
J Pediatr Nurs; 2016; 31(2):e155-66. PubMed ID: 26586310
[TBL] [Abstract][Full Text] [Related]
10. Providers' beliefs about the effectiveness of the HPV vaccine in preventing cancer and their recommended age groups for vaccination: Findings from a provider survey, 2012.
Berkowitz Z; Malone M; Rodriguez J; Saraiya M
Prev Med; 2015 Dec; 81():405-11. PubMed ID: 26598805
[TBL] [Abstract][Full Text] [Related]
11. Improving Human Papillomavirus Vaccine Use in an Integrated Health System: Impact of a Provider and Staff Intervention.
McLean HQ; VanWormer JJ; Chow BDW; Birchmeier B; Vickers E; DeVries E; Meyer J; Moore J; McNeil MM; Stokley S; Gee J; Belongia EA
J Adolesc Health; 2017 Aug; 61(2):252-258. PubMed ID: 28462786
[TBL] [Abstract][Full Text] [Related]
12. Examining HPV Vaccination Practices and Differences Among Providers in Virginia.
Alcalá HE; Maxwell GL; Lindsay B; Keim-Malpass J; Mitchell EM; Balkrishnan R
J Cancer Educ; 2020 Feb; 35(1):159-164. PubMed ID: 30520008
[TBL] [Abstract][Full Text] [Related]
13. Relative contributions of parental intention and provider recommendation style to HPV and meningococcal vaccine receipt.
Eun TJ; Hanchate A; Fenton AT; Clark JA; Aurora MN; Drainoni ML; Perkins RB
Hum Vaccin Immunother; 2019; 15(10):2460-2465. PubMed ID: 30862301
[TBL] [Abstract][Full Text] [Related]
14. Predictors of Human Papillomavirus Vaccine Completion Among Low-Income Latina/o Adolescents.
Gerend MA; Stephens YP; Kazmer MM; Slate EH; Reyes E
J Adolesc Health; 2019 Jun; 64(6):753-762. PubMed ID: 30777636
[TBL] [Abstract][Full Text] [Related]
15. A population-level assessment of factors associated with uptake of adolescent-targeted vaccines in Michigan.
Gowda C; Dong S; Potter RC; Dombkowski KJ; Dempsey AF
J Adolesc Health; 2013 Oct; 53(4):498-505. PubMed ID: 24054080
[TBL] [Abstract][Full Text] [Related]
16. Parents' and providers' attitudes toward school-located provision and school-entry requirements for HPV vaccines.
Vercruysse J; Chigurupati NL; Fung L; Apte G; Pierre-Joseph N; Perkins RB
Hum Vaccin Immunother; 2016 Jun; 12(6):1606-14. PubMed ID: 26934421
[TBL] [Abstract][Full Text] [Related]
17. Human Papillomavirus Vaccine: Continuation, Completion, and Missed Opportunities.
Richards MJ; Peters M; Sheeder J
J Pediatr Adolesc Gynecol; 2016 Apr; 29(2):117-21. PubMed ID: 26300233
[TBL] [Abstract][Full Text] [Related]
18. Implementation of a Postpartum HPV Vaccination Program in a Southeast Texas Hospital: A Qualitative Study Evaluating Health Care Provider Acceptance.
Gross TT; Rahman M; M Wright A; M Hirth J; Sarpong KO; Rupp RE; D Barrett A; Berenson AB
Matern Child Health J; 2016 Nov; 20(Suppl 1):154-163. PubMed ID: 27316631
[TBL] [Abstract][Full Text] [Related]
19. Clinician knowledge, clinician barriers, and perceived parental barriers regarding human papillomavirus vaccination: Association with initiation and completion rates.
Rutten LJ; St Sauver JL; Beebe TJ; Wilson PM; Jacobson DJ; Fan C; Breitkopf CR; Vadaparampil ST; Jacobson RM
Vaccine; 2017 Jan; 35(1):164-169. PubMed ID: 27887795
[TBL] [Abstract][Full Text] [Related]
20. Provider communication and HPV vaccination: The impact of recommendation quality.
Gilkey MB; Calo WA; Moss JL; Shah PD; Marciniak MW; Brewer NT
Vaccine; 2016 Feb; 34(9):1187-92. PubMed ID: 26812078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
